# Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol

> **NCT04989348** · NA · COMPLETED · sponsor: **Shanghai First Maternity and Infant Hospital** · enrollment: 240 (actual)

## Conditions studied

- IVF

## Interventions

- **PROCEDURE:** Gonadotrophin releasing hormone antagonist protocol
- **PROCEDURE:** Progestin-primed ovarian stimulation protocol

## Key facts

- **NCT ID:** NCT04989348
- **Lead sponsor:** Shanghai First Maternity and Infant Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-04
- **Primary completion:** 2023-03-01
- **Final completion:** 2024-02-20
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04989348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04989348, "Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04989348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*